These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 11419855)
1. Surgery versus medical therapy for gastroesophageal reflux disease. DeVault KR Am J Gastroenterol; 2001 Jun; 96(6):1932-3. PubMed ID: 11419855 [No Abstract] [Full Text] [Related]
2. [Medical treatment efficient in chronic reflux. Also surgery has a given place in long-term therapy--for certain patients]. Lundell L Lakartidningen; 2009 Feb 18-24; 106(8):502-5. PubMed ID: 19350782 [No Abstract] [Full Text] [Related]
4. Whither surgery in the treatment of gastroesophageal reflux disease (GERD)? Urbach DR; Ungar WJ; Rabeneck L CMAJ; 2004 Jan; 170(2):219-21. PubMed ID: 14734435 [No Abstract] [Full Text] [Related]
5. A randomized controlled trial of laparoscopic nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: One-year follow-up. Anvari M; Allen C; Marshall J; Armstrong D; Goeree R; Ungar W; Goldsmith C Surg Innov; 2006 Dec; 13(4):238-49. PubMed ID: 17227922 [TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study. van Grieken NC; Meijer GA; Weiss MM; Bloemena E; Lindeman J; Baak JP; Meuwissen SG; Kuipers EJ Am J Gastroenterol; 2001 Oct; 96(10):2882-6. PubMed ID: 11693321 [TBL] [Abstract][Full Text] [Related]
7. The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--pharmacoeconomics and its application to antisecretory drugs: a case study. Morreale A Manag Care Interface; 2001; Suppl B():28-30; discussion 31-3. PubMed ID: 11569296 [No Abstract] [Full Text] [Related]
8. N-(2-hydroxyethyl)-N,2-dimethyl-8-{[(4R)-5-methyl-3,4-dihydro-2H-chromen-4-yl]amino}imidazo[1,2-a]pyridine-6-carboxamide (PF-03716556), a novel, potent, and selective acid pump antagonist for the treatment of gastroesophageal reflux disease. Mori H; Tonai-Kachi H; Ochi Y; Taniguchi Y; Ohshiro H; Takahashi N; Aihara T; Hirao A; Kato T; Sakakibara M; Kurebayashi Y J Pharmacol Exp Ther; 2009 Feb; 328(2):671-9. PubMed ID: 18981288 [TBL] [Abstract][Full Text] [Related]
9. Acid-related disorders and use of antisecretory medication. Lassen AT Dan Med Bull; 2007 Feb; 54(1):18-30. PubMed ID: 17349216 [No Abstract] [Full Text] [Related]
10. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients. Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449 [TBL] [Abstract][Full Text] [Related]
11. Omeprazole maintenance therapy for GERD. Parks SM J Fam Pract; 1997 Oct; 45(4):292-3. PubMed ID: 9379150 [No Abstract] [Full Text] [Related]
12. Treatment of gastroesophageal reflux: the role of proton pump inhibitors. Schulman MI; Orlando RC Adv Intern Med; 1995; 40():273-302. PubMed ID: 7747649 [No Abstract] [Full Text] [Related]